Tocqueville Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.57M Sell
59,933
-884
-1% -$116K 0.1% 177
2026
Q1
$8.48M Sell
60,817
-13,927
-19% -$1.95M 0.13% 169
2025
Q4
$9.17M Sell
74,744
-21
-0% -$2.55K 0.13% 168
2025
Q3
$8.3M Sell
74,765
-16
-0% -$1.82K 0.12% 180
2025
Q2
$8.29M Buy
74,781
+399
+0.5% +$42.5K 0.13% 172
2025
Q1
$8.33M Sell
74,382
-815
-1% -$84.1K 0.14% 140
2024
Q4
$6.95M Sell
75,197
-600
-0.8% -$54K 0.11% 155
2024
Q3
$6.35M Sell
75,797
-6,105
-7% -$466K 0.1% 164
2024
Q2
$5.62M Sell
81,902
-9,953
-11% -$664K 0.09% 165
2024
Q1
$6.73M Sell
91,855
-693
-0.7% -$53.3K 0.11% 160
2023
Q4
$7.5M Sell
92,548
-1,407
-1% -$109K 0.14% 148
2023
Q3
$7.04M Buy
93,955
+166
+0.2% +$12.8K 0.13% 153
2023
Q2
$7.23M Sell
93,789
-827
-0.9% -$66K 0.13% 151
2023
Q1
$7.85M Buy
94,616
+225
+0.2% +$18.6K 0.15% 144
2022
Q4
$8.1M Sell
94,391
-48,715
-34% -$3.86M 0.15% 146
2022
Q3
$8.83M Buy
143,106
+16,905
+13% +$1.07M 0.18% 133
2022
Q2
$7.8M Sell
126,201
-6,200
-5% -$384K 0.14% 159
2022
Q1
$7.87M Sell
132,401
-45,023
-25% -$2.88M 0.12% 175
2021
Q4
$12.9M Sell
177,424
-158,975
-47% -$10.9M 0.18% 125
2021
Q3
$23.5M Buy
336,399
+55
+0% +$3.86K 0.35% 71
2021
Q2
$23.2M Buy
336,344
+9,995
+3% +$667K 0.33% 78
2021
Q1
$21.1M Buy
326,349
+315,154
+2,815% +$20.3M 0.32% 81
2020
Q4
$652K Sell
11,195
-1,600
-13% -$96.5K 0.01% 497
2020
Q3
$809K Sell
12,795
-15,047
-54% -$1.04M 0.02% 422
2020
Q2
$2.14M Sell
27,842
-8,215
-23% -$630K 0.04% 291
2020
Q1
$2.7M Sell
36,057
-1,562
-4% -$108K 0.07% 239
2019
Q4
$2.44M Sell
37,619
-3,197
-8% -$208K 0.04% 333
2019
Q3
$2.59M Sell
40,816
-675
-2% -$44.1K 0.04% 344
2019
Q2
$2.8M Sell
41,491
-50
-0.1% -$3.29K 0.04% 355
2019
Q1
$2.7M Sell
41,541
-23,282
-36% -$1.55M 0.04% 353
2018
Q4
$4.05M Sell
64,823
-14,304
-18% -$1,000K 0.06% 287
2018
Q3
$6.11M Sell
79,127
-667
-0.8% -$50.4K 0.08% 260
2018
Q2
$5.65M Buy
79,794
+175
+0.2% +$12.4K 0.07% 277
2018
Q1
$6M Sell
79,619
-7,098
-8% -$564K 0.08% 272
2017
Q4
$6.21M Sell
86,717
-41,212
-32% -$3.13M 0.07% 276
2017
Q3
$10.4M Buy
127,929
+92,796
+264% +$7.1M 0.12% 205
2017
Q2
$2.49M Buy
35,133
+757
+2% +$50.4K 0.03% 401
2017
Q1
$2.33M Sell
34,376
-64,931
-65% -$4.57M 0.03% 401
2016
Q4
$7.11M Sell
99,307
-43,367
-30% -$3.22M 0.09% 235
2016
Q3
$11.3M Sell
142,674
-85,317
-37% -$6.93M 0.14% 181
2016
Q2
$19M Sell
227,991
-21,047
-8% -$1.87M 0.23% 108
2016
Q1
$22.9M Buy
249,038
+3,070
+1% +$277K 0.3% 94
2015
Q4
$24.9M Buy
245,968
+1,763
+0.7% +$183K 0.34% 89
2015
Q3
$24M Sell
244,205
-931
-0.4% -$103K 0.32% 95
2015
Q2
$28.7M Buy
245,136
+11,108
+5% +$1.21M 0.34% 89
2015
Q1
$23M Sell
234,028
-36,673
-14% -$3.72M 0.27% 118
2014
Q4
$25.5M Buy
270,701
+4,481
+2% +$463K 0.27% 117
2014
Q3
$28.3M Sell
266,220
-1,313
-0.5% -$129K 0.31% 102
2014
Q2
$22.2M Sell
267,533
-1,506
-0.6% -$117K 0.22% 136
2014
Q1
$19.1M Buy
269,039
+18,779
+8% +$1.47M 0.25% 121
2013
Q4
$18.8M Buy
250,260
+2,344
+0.9% +$163K 0.25% 118
2013
Q3
$15.6M Buy
247,916
+14,201
+6% +$849K 0.19% 146
2013
Q2
$12M Buy
+233,715
New +$12.2M 0.16% 165

Other funds holding GILD

Tocqueville Asset Management's GILD Position: Q2 2026 in Review

Tocqueville Asset Management reduced its Gilead Sciences (GILD) stake by 1.5% in Q2 2026, selling an estimated $116K and leaving 59,933 shares worth $7.57M. The position accounts for 0.1% of the portfolio, ranked #177.

Tocqueville Asset Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $28.7M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Tocqueville Asset Management held 59,933 shares of Gilead Sciences worth $7.57M as of Q2 2026.
  • Tocqueville Asset Management sold 884 Gilead Sciences shares in Q2 2026, an estimated $116K.
  • Gilead Sciences made up 0.1% of Tocqueville Asset Management's portfolio in Q2 2026, its #177 holding.
  • Tocqueville Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Tocqueville Asset Management's Gilead Sciences position peaked at $28.7M in Q2 2015.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.